España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Kyverna Therapeutics
KYTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.00
0.13
3.36%
At close: -
$4.00
0.00
0.00%
After Hours: 4:01 PM EDT
Get Report
Comment
Kyverna Therapeutics (KYTX) Forecast
News
Earnings
Kyverna Therapeutics (KYTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Kyverna Therapeutics (NASDAQ:KYTX) Stock
Kyverna Therapeutics Stock (NASDAQ: KYTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 20, 2024
HC Wainwright & Co. Maintains Neutral on Kyve...
Benzinga Newsdesk
Friday, November 15, 2024
Wells Fargo Maintains Overweight on Kyverna T...
Benzinga Newsdesk
Wednesday, November 13, 2024
Kyverna Therapeutics Q3 EPS $(0.80), Inline
Benzinga Newsdesk
Thursday, October 10, 2024
UBS Initiates Coverage On Kyverna Therapeutic...
Benzinga Newsdesk
Thursday, September 19, 2024
HC Wainwright & Co. Reiterates Neutral on Kyv...
Benzinga Newsdesk
Wednesday, September 18, 2024
Kyverna Therapeutics Presents Patient Data Re...
Benzinga Newsdesk
Monday, September 16, 2024
Kyverna Therapeutics Announces Leadership Upd...
Benzinga Newsdesk
Wednesday, August 21, 2024
Toll Brothers Posts Strong Earnings, Joins Keysight, Coty, TJX And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Thursday, August 15, 2024
HC Wainwright & Co. Maintains Neutral on Kyve...
Benzinga Newsdesk
Tuesday, August 13, 2024
Home Depot, Paysafe And 3 Stocks To Watch Heading Into Tuesday
Avi Kapoor
Monday, August 12, 2024
Kyverna Therapeutics Q2 EPS $(0.67) Misses $(...
Benzinga Newsdesk
Kyverna Therapeutics shares are trading highe...
Benzinga Newsdesk
Kyverna Therapeutics Receives U.S. FDA RMAT D...
Benzinga Newsdesk
Wednesday, July 31, 2024
JP Morgan Maintains Overweight on Kyverna The...
Benzinga Newsdesk
Friday, July 19, 2024
Cell Therapy Mostly Used For Blood Cancer Shows Efficacy In Autoimmune Diseases As Well, But There Are Challenges
Vandana Singh
Tuesday, July 16, 2024
HC Wainwright & Co. Reiterates Neutral on Kyv...
Benzinga Newsdesk
Bank Of America, Morgan Stanley And Other 3 Stocks To Watch Heading Into Tuesday
Avi Kapoor
Monday, July 15, 2024
Kyverna Therapeutics shares are trading highe...
Benzinga Newsdesk
Kyverna's KYV-101 Receives U.S. FDA Regenerat...
Benzinga Newsdesk
Wednesday, July 03, 2024
HC Wainwright & Co. Initiates Coverage On Kyv...
Benzinga Newsdesk
Thursday, June 20, 2024
Kyverna Therapeutics shares are trading highe...
Benzinga Newsdesk
FDA Authorizes Clearance For Kyverna's KYV-10...
Benzinga Newsdesk
Monday, June 17, 2024
Kyverna Therapeutics Presents First-In-Diseas...
Benzinga Newsdesk
Friday, June 14, 2024
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Why Kyverna Therapeutics Stock Is Sinking
Erica Kollmann
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Kyverna Therapeutics shares are trading lower...
Benzinga Newsdesk
Dow Tumbles Over 200 Points; Adobe Earnings Top Views
Avi Kapoor
Thursday, June 13, 2024
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Friday, June 07, 2024
Kyverna Therapeutics To Present Data From Coh...
Benzinga Newsdesk
Monday, June 03, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Tuesday, May 14, 2024
Kyverna Therapeutics Q1 2024 Adj EPS $(1.12) ...
Benzinga Newsdesk
Monday, April 29, 2024
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Thursday, April 11, 2024
Kyverna Therapeutics To Attend The 2024 AAN A...
Benzinga Newsdesk
Monday, April 01, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Tuesday, March 26, 2024
Kyverna Therapeutics FY23 EPS $(89.61) Vs $(6...
Benzinga Newsdesk
Friday, March 08, 2024
Kyverna Therapeutics And Stanford University ...
Benzinga Newsdesk
Monday, March 04, 2024
JP Morgan Initiates Coverage On Kyverna Thera...
Benzinga Newsdesk
Morgan Stanley Initiates Coverage On Kyverna ...
Benzinga Newsdesk
Thursday, February 08, 2024
Kyverna Therapeutics IPO Shares Open For Trad...
Benzinga Newsdesk
IPO For Kyverna Therapeutics Is Open For Quot...
Benzinga Newsdesk
Trading Halt: Halt status updated at 10:10:00...
Benzinga Newsdesk
Kyverna Therapeutics Prices Upsized Initial P...
Benzinga Newsdesk
Wednesday, February 07, 2024
Kyverna Therapeutics, Inc To Start Trading Tomorrow
Benzinga Insights
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch